UMM Institutional Repository

STUDI PENGGUNAAN ERITROPOIETIN PADA PASIEN CHRONIC KIDNEY DISEASE (Penelitian dilakukan di RSUD Dr. Iskak Tulungagung)

Beines, Viviani (2018) STUDI PENGGUNAAN ERITROPOIETIN PADA PASIEN CHRONIC KIDNEY DISEASE (Penelitian dilakukan di RSUD Dr. Iskak Tulungagung). Undergraduate (S1) thesis, University of Muhammadiyah Malang.

[img]
Preview
Text
Pendahuluan.pdf

Download (4MB) | Preview
[img]
Preview
Text
BAB I.pdf

Download (1MB) | Preview
[img]
Preview
Text
BAB II.pdf

Download (9MB) | Preview
[img]
Preview
Text
BAB III.pdf

Download (699kB) | Preview
[img]
Preview
Text
BAB IV.pdf

Download (914kB) | Preview
[img]
Preview
Text
BAB V.pdf

Download (5MB) | Preview
[img] Text
BAB VI.pdf
Restricted to Registered users only

Download (1MB)
[img] Text
BAB VII.pdf
Restricted to Registered users only

Download (236kB)
[img] Text
Lampiran.pdf
Restricted to Registered users only

Download (2MB)

Abstract

Background: Chronic Kidney Disease (CKD) is an abnormality of kidney in its structure and function that occurs along 3 months or more. Anemia occurs in 80-90% of CKD patients. Erythropoietin (EPO) is a glycoprotein hormone that regulates the production of red blood cell precursors, produced in the kidneys in response to tissue hypoxia. The decreasing in EPO production is a major cause of anemia in CKD. Objective: This study is aimed to examine the pattern of Eritropoietin used in Chronic Kidney Disease (CKD) patient including also the type, dose, route, frequency, and duration of administration at Dr. Iskak Hospital in Tulungagung. Method: This study employed retrospective observational with the descriptive data presentation from CKD patient from October 2017 - December 2017 period. Results and Conclusions: Erythropoietin was administered in 100 patients. The therapy that was given to the patient is the single therapy (100%) and combination therapy (0%). The type of Erythropoietin used in epoetin alpha (98%) and epoetin beta (2%). The doses administered by each patient are the same which is (1x2000 IU) SC and (1x3000 IU) SC. The route type of Erythropoietin is Subcutaneous (100%).

Item Type: Thesis (Undergraduate (S1))
Student ID: 201410410311238
Keywords: Erythropoietin, Chronic Kidney Disease, Anemia
Subjects: R Medicine > RX Homeopathy
Divisions: Faculty of Health Science > Department of Pharmacy (48201)
Depositing User: Nurhadin Nurhadin
Date Deposited: 26 Dec 2018 05:22
Last Modified: 26 Dec 2018 05:22
URI : http://eprints.umm.ac.id/id/eprint/42585

Actions (login required)

View Item View Item
UMM Official

© 2008 UMM Library. All Rights Reserved.
Jl. Raya Tlogomas No 246 Malang East Java Indonesia - Phone +62341464318 ext. 150, 151 - Fax +62341464101
E-Mail : infopus[at]umm.ac.id - Website : http://lib.umm.ac.id - Online Catalog : http://laser.umm.ac.id - Repository : http://eprints.umm.ac.id

Web Analytics

UMM Institutional Repository is powered by :
EPrints Logo